Colgate-Palmolive (CL) Tops Q4 EPS by 1c, Comments on Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St indexes eye weekly losses; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Colgate-Palmolive Company (CL) PT Lowered to $57 at Macquarie
January 29, 2019 6:52 AM ESTMacquarie analyst Caroline Levy lowered the price target on Colgate-Palmolive Company (NYSE: CL) to $57.00 (from $60.00) while maintaining a Neutral rating. Macquarie cut 2019 EPS estimates to $2.84, 2020 to $3.00 and 2021 to $3.20 (from $2.95, $3.13 and $3.33), for lower ebit margin outlook.
Levy remains cautious on the outlook for the... More
